CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL
Product details
Registration number: SIN14658P
Classification: Prescription Only
Active ingredients: CEFEPIME HYDROCHLORIDE 1189 mg EQV CEFEPIME BASE
Strength: 1000MG
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Registrant: APEX PHARMA MARKETING PTE. LTD.
ATC code: J01DE01
HSA approval date: 6 November 2014
Manufacturer(s):
- QILU PHARMACEUTICAL CO., LTD
- QILU ANTIBIOTICS PHARMACEUTICAL CO., LTD (Blend-Cefepime Hydrochloride (Contains Arginine))
Manufacturing country/countries: CHINA
What are the HSA registration number and classification for CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14658P
Classification: Prescription Only
What active ingredients and strength are recorded for CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: CEFEPIME HYDROCHLORIDE 1189 mg EQV CEFEPIME BASE
Strength: 1000MG
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Who is the recorded registrant for CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: APEX PHARMA MARKETING PTE. LTD.
Which manufacturers and countries are listed for CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- QILU PHARMACEUTICAL CO., LTD
- QILU ANTIBIOTICS PHARMACEUTICAL CO., LTD (Blend-Cefepime Hydrochloride (Contains Arginine))
Manufacturing country/countries: CHINA
Where can I look up CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14658P or the exact product name CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL. The general register link does not preselect this product.
What are the source dates for this CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CEFEPIME-AFT POWDER FOR INJECTION 1G/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14658P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)